Today CBD products are appearing in medicine cabinets across America, and while this increasingly popular cannabinoid is available in a variety of products, there is one delivery method that has proved to be unpredictably popular with consumers — CBD gummies. What makes a gummy? Many people who use CBD oil prefer to ingest the substance orally in the form of an edible or capsule. Gummies are becoming one of the most preffered was to consume CBD. As more and more retailers are entering this rapidly expanding CBD industry, nearly everyone entering the game has a chewy, sweet gummy offering for potential customers from different age group. Most times, gummies areenhanced with organic product juice and other characteristic fixings, giving them a particular, lovely taste that covers the flavor of CBD (which some discover severe and disagreeable). Gummies are also soft and easy to chew, making them a good option for people with dentures or other dental issues who are not well-suited for harder capsules. Gummies come in a wide range of concentrations, from low-dose 1mg to 10mg options to high-dose gummies of up to 100mg per serving.

In this article we will explore, what is a CBD gummy and why CBD gummies have struck such a nerve with consumers?

What Is CBD (Cannabidiol)?

Cannabidiol, or CBD, is a cannabinoid found in cannabis plants. Cannabinoids are natural compounds that, when introduced to the human body, react with a communication center known as the endocannabinoid system. These interactions have an effect on functions like appetite, sleep, pain, and mood. As a result, products containing CBD can alleviate symptoms associated with the following conditions:

  • Insomnia, other sleep disorders, and general difficulty falling and staying asleep,
  • Anxiety and stress,
  • Chronic pain,
  • Epilepsy,
  • Cancer and other diseases that affect the immune system,
  • Nausea.

Many relate cannabis with marijuana and getting high. However, CBD is different from other tetrahydrocannabinol (THC) and other cannabinoids found in cannabis because it does not produce any psychoactive effects on its own.

CBD may cause sentiments of unwinding and sluggishness, yet it won’t make a high.. That being said, quite a few CBD products also contain trace amounts of THC (less than .03%); these products create more of a psychoactive high. Most CBD gummies have low to none THC.

Although some CBD oil is synthetically produced, most CBD products are derived from hemp plants. Historically, legal restrictions have limited the production, sale, and consumption of hemp-based products. However, passage of the 2018 Farm Bill led to the federal decriminalization of these activities. As a result, non-THC CBD oil products derived from hemp are legal to sell, buy, and use/consume anywhere in the U.S. In states where recreational cannabis is legal, CBD products containing THC are also legal. Other state laws vary considerably by location.

CBD 2 Species: Marijuana and Hemp Gummies

Some Medical Benefits of CBD Gummies

According to a 2018 survey, almost 62% of CBD users took CBD to manage a health condition. Three of the most widely reported reasons were pain, anxiety, and depression. 36% described that CBD treated their condition “very well by itself”. Only 4.3% participants reported, “not very well.”

Here are the most common CBD gummies’ uses and how they alleviate certain symptoms:

CBD and Various Types of Pain

As state before, the use of CBD gummies for potential pain benefits becoming widely common practice. Namely, CBD can make a difference when it comes to arthritis pain. A study examined the efficacy of orally administered CBD to decrease hypersensitivity and inflammation. The researchers noted long-lasting therapeutic effects without causing a psychoactive feeling. The benefits of CBD gummies are helpful for chronic pain. The same report studied how consumption of CBD causes relief from chronic pain and leads to many patients switching the use of opioids for cannabinoids. The condition underlying chronic pain was most often related to neuropathy, musculoskeletal issues, and cancer-related pain.

CBD and Anxiety

Taking into account the role of the EDS in mood regulation, there are many reasons to explore CBD gummies for anxiety treatment. There is still limited evidence on the improvement of anxiety symptoms. However, CBD was observed to have short-term benefits, as assessed by a public speaking test in people, with social anxiety. Therefore, CBD is an interesting pharmacological approach to reduce the anxiogenic impact of stress. It may also promote the extinction of fear memories.

CBD and Depression

After decades of studying depression, many conventional treatments don’t seem to work. The scientific community has unearthed more evidence, which meets this need. It supports the idea that CBD gummies effects help patients cope with depression. CBD induces antidepressant-like effects comparable to those of imipramine, a tricyclic antidepressant. Results indicate that CBD has an antidepressant-like profile and could be a new pharmacological target for the treatment of major mental imbalances.

Insomnia

Another medical application is eating CBD gummies for sleep. Research shows the administration of CBD may increase overall amounts of sleep. Additionally, it was found to reduce insomnia. Experts point out that CBD help with the sleep-promoting chemical and cause drowsiness. If a person needs help falling asleep or simply relaxing, CBD gummies have that effect without the person feeling groggy. This is usually the case with other medication.

Other Uses

Do CBD gummies work in other situations? Although more research is required to confirm additional uses of CBD-infused products, it is shaping up as a potentially promising and versatile method of treatment. CBD may help in cases of: Nicotine withdrawal, Epilepsy, Acne, Type 1 diabetes, etc.

Also, the research found conclusive evidence through patient-reported symptoms associated with multiple sclerosis (MS). It should be mentioned that orally administered CBD extract is not as good for short-term improvements (6–15 weeks) as products taken for a year. Still, CBD treatment for spasticity in people with spinal cord injuries needs further research.

What Makes a Gummy?

In many ways, gummy supplements contain the same ingredients as classic gummy candies—gelatin, sugar, and a little bit of added flavor. In addition to these basic ingredients, companies like Every Day Optimal add a little extra CBD extract to their CBD gummies. Derived from hemp cannabis plants, this extract is high in cannabidiol, or CBD, and contains less than 0.3% THC, making it legal for products sold online and delivered coast to coast. Where the hemp plants used to make CBD is sourced from, though, makes a big difference to Every Day Optimal. Their team has worked to build relationships with US farmers and source their CBD only from domestically grown hemp. Working with trusted farmers close to home allows Every Day Optimal to maintain a thorough understanding of their partner’s practices and products. That understanding—backed up by third-party independent testing of each product in their catalog—helps ensure that customers know exactly what they’re getting from products like Every Day Optimal’s CBD gummies.

What is a gummy? CBD Gummies chart Effects

How Do Gummies Differ from Other CBD Products?

Gummies offer a unique experience for CBD consumers that set them apart from tinctures, topicals, and other forms of CBD. Common properties of CBD gummies include the following:

  • Edible: Because gummies are consumed orally, they – like other CBD edibles – typically produce longer-lasting effects than other forms of CBD oil, such as tinctures or vape oils. However, the level of effects also depends on the gummy’s CBD concentration.
  • Concentration: A CBD gummy may have a concentration of up to 100mg, but most have concentrations of 30mg per capsule or lower. The ideal CBD concentration depends on the consumer’s body weight and CBD tolerance, as well as the amount of pain relief they desire. For most people who weigh less than 200 pounds and have moderate to severe pain, a 30mg CBD serving is sufficient. Those who weigh more than 200 pounds may prefer to take higher concentrations.
  • Isolate vs. full spectrum: Whether a CBD oil is considered isolate or full-spectrum depends on how the oil is formulated. Isolate CBD oils only contain THC, while full-spectrum oils retain the CBD along with other non-psychoactive cannabinoids like cannabicyclol (CBL) and cannabinol (CBN), essential oils known as terpenes, and other nutrients. Most CBD gummies sold today are full-spectrum because they produce more well-rounded feelings of relaxation and pain relief, which make them popular with consumers. However, some gummies are made from CBD isolate.
  • Flavor: CBD gummies come in a wide range of flavors, including fruity and herbal options. CBD has a naturally strong taste that some people dislike, and some flavored gummies mask the taste of CBD very well.
  • Sugar content: Some CBD gummies contain sugar, which makes them unsuitable for consumers with certain medical conditions (such as diabetes). However, most gummies have fairly low sugar content. Additionally, most gummies contain at least 10mg of CBD and consumers will not eat more than three to four per dose. For those seeking sugar-free CBD gummies, plenty of options are available, as well.
  • Gluten-free/vegan: CBD consumers who are vegan or unable to eat gluten products can choose from a wide selection of gluten-free, vegan gummies. However, some gummies do not meet either/both of these criteria. For this reason, customers with these restrictions should carefully read the product label and reach out to company representatives if necessary.
  • Price: Price-points for CBD gummies vary by brand and individual product, but most are available for 20 cents per mg or less; this puts gummies on par with other CBD oil products in terms of overall cost. Keep in mind that ‘per mg’ refers to the total CBD concentration found in the container, and not the number of gummies. For instance, let’s say a container of 30 5mg gummies is priced at $20. This puts the container at roughly 13 cents per mg, and roughly 67 cents per gummy.

Do CBD Gummies Get You High?

CBD gummies produce feelings of relaxation in consumers; they also alleviate pains and other discomforts stemming from symptoms of different medical conditions. However, non-THC CBD gummies will not make consumers feel high in the same way that marijuana and other products with THC will. This is because CBD does not produce psychoactive effects like THC does.

Some – but not all – full-spectrum gummies with contain trace amounts of THC; in most cases, these products contain 0.3% of THC or less. They may cause extremely slight psychoactive effects but will not produce the same high as, say, edibles containing marijuana (which can be as much as 30% THC or higher).

And although CBD gummies may not produce a psychoactive high, they often cause consumers to feel sleepy. As a result, we advise consumers not to take CBD gummies if they plan to work with machinery, operate a motor vehicle, or engage in other activities that require full motor skills.

The Right Dosage for CBD Gummies 

A CBD gummy may contain anywhere from 1mg to 100mg of CBD. However, most gummies sold today contain between 5mg and 30mg.

As we’ve noted, the optimal dosage for any given consumer will depend on his/her weight, tolerance to CBD, and desired effects. The table below lists general CBD concentration ranges for people based on their weight. However, we urge all first-time CBD consumers to begin with a relatively small dose (10mg or less) and then gradually increase the dosage until the desired effects are reached; this will likely create a more pleasurable experience than beginning with a high dose.

 

Weight Group Optimal Dose for Light Effects Optimal Dose for Moderate Effects Optimal Dose for Strong Effects
Less than 130 lbs 10mg to 11mg or less 12mg to 14mg 15mg to 17mg
130 to 230 lbs. 17mg to 18mg or less 19mg to 23mg 24mg to 27mg
More than 230 lbs 22mg to 23mg 24mg to 30mg 31mg to 42mg

How to Choose a the best CBD Gummies

If you want to start your CBD journey with a successful outcome, then you should begin by educating yourself on certain brands and what they offer. As the medical marijuana industry is getting increasingly bigger, more companies are popping up online selling gummies, tinctures, and other CBD edibles. Before you make any kind of investment, be sure that the brand you buy from offers the following:

  • Pesticide-free, non-GMO products
  • Complete transparency with regards to dosage
  • Third-party lab testing
  • Chemical-free products
  • The legal amount of THC
  • Natural additives and flavorings
  • Infused with full spectrum CBD oil
  • No chemical solvents
  • CO2 extraction method for purity

The market for various CBD-infused products is growing at an extremely fast rate. You may already know that CBD-based products take various forms: chocolate, tinctures, olive oil, vapes, gummies, etc. But no edible product has come remotely close to the popularity of CBD gummies. CBD gummies have become one of the most sought-after medicines. Hopefully, this article has helped you to better understand CBD gummies and the powerful benefits that it can provide, and the right dosage but most importantly, how to buy CBD gummies from online.

References:

Volkow, Nora D. “Cannabidiol: Barriers to Research and Potential Medical Benefits.” Drug Caucus Hearing on Barriers to Cannabidiol Research, United States Senate Caucus on International Narcotics Control. June 24, 2015 Retrieved from

https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2016/biology-potential-therapeutic-effects-cannabidiol

Ligresti et al. “Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.” J Pharmacol Exp Ther 318.3 (2006): 1375-1387.

Massi et al. “Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.” J Pharmacol Exp Ther 308.3 (2004): 838-845.

McAllister et al. “The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.” J Neuroimmune Pharmacol 10.2 (2015): 255-267.

Esposito et al. “The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells.” J Mol Med (Berl) 84.3 (2006): 253-258.

Martín-Moreno et al. “Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease.” Mol Pharmacol 79.6 (2011): 964-973.

Iuvone et al. “Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells.” J Neurochem 89.1 (2004): 134-141.

Pazos et al. “Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5-HT1A and CB2 receptors.” Neuropharmacology 71 (2013): 282-291.

Hampson et al. “Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.” Proc Natl Acad Sci USA 95.14 (1998): 8268-8273.

Pryce et al. “Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.” J Neuroimmune Pharmacol 10.2 (2015): 281-292.

García-Arencibia et al. “Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent properties.” Brain Res 1134.1 (2007): 162-170.

Fusar-Poli et al. “Distinct effects of delta-9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.” Arch Gen Psychiatry 66.1 (2009): 95-105.

Schier et al. “Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.” Rev Bras Psiquiatr, 34.1 (2012): 104-110.

Zuardi et al. “Effect of cannabidiol on plasma prolactin, growth hormone, and cortisol in human volunteers.” Braz J of Med and Biol Res 26.2 (1993): 213–217.

Malfait et al. “The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.” Proc Natl Acad Sci USA 97.17 (2000): 9561-9566.

Costa et al. “Oral anti-inflammatory activity of cannabidiol, a nonpsychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw.” Naunyn Schmiedebergs Arch Pharmacol 369.3 (2004): 294-299.

Costa et al. “The nonpsychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.” Eur J Pharmacol. 556.1-3 (2006): 75-83.

Di Marzo, Vincenzo and Diego Centonze. ‘Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes.” CNS Neurosci Ther. 21.3 (2015): 215-21.

Flachenecker et al. “Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice–results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.” Eur Neurol. 71.5-6 (2014): 271-279.

Porter, Brenda E. and Catherine Jacobson “Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.” Epilepsy & Behavior 29 (2013) 574–577.

Cunha et al. “Chronic administration of cannabidiol to healthy volunteers and epileptic patients.” Pharmacology 21.3 (1980): 175-185.

Parker et al. “Cannabidiol, a nonpsychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats.” Neuroreport. 13.5 (2002): 567-570.

Weiss et al. “Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.” Autoimmunity. 39.2 (2006): 143-151.

Rajesh et al. “Cannabidiol attenuates high glucoseinduced endothelial cell inflammatory response and barrier disruption.” Am J Physiol Heart Circ. Physiol. 293.1 (2007): H610-H619.

Porter, Brenda E. and Catherine Jacobson. “Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.” Epilepsy & Behavior 29.3 (2013): 574–577.

Lee, Martin A. “CBD Misconceptions.” Project CBD. February 18, 2015. Accessed October 28, 2016. https://www.projectcbd.org/article/cbd-misconceptions.

Russo, Ethan B. “Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.” Br J Pharmacol. 163.7 (2011): 1344-1364.